NIH | National Cancer Institute | NCI Wiki  

WIKI MAINTENANCE NOTICE

Please be advised that NCI Wiki will be undergoing maintenance on Thursday, May 23rd between 1200 ET and 1300 ET.
Wiki will remain available, but users may experience screen refreshes or HTTP 502 errors during the maintenance period. If you encounter these errors, wait 1-2 minutes, then refresh your page.

If you have any questions or concerns, please contact the CBIIT Atlassian Management Team.

Error rendering macro 'rw-search'

null

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 12 Next »

Complete this section only if you indicated that you require an XML document to register your trial with ClinicalTrials.gov.

The system will not display this section if you indicated that you do not require an XML document for ClinicalTrials.gov.

How to Complete the Regulatory Information Section

Select or enter the appropriate information in the text fields and drop-down lists. The following table describes the fields. An asterisk (*) indicates a required field. See the ClinicalTrials.gov Protocol Data Element Definitions for definitions for these fields.

Instructions for recording regulatory information

Field Label

Description/Instructions

Studies a U.S. FDA-regulated Drug Product*

If the trial studies one or more U.S. FDA-regulated drug or biologic products (a drug subject to section 505 of the Federal Food, Drug, and Cosmetic Act or a biological product subject to section 351 of the Public Health Service Act), select Yes. Otherwise, select No.

Studies a U.S. FDA-regulated Device Product*

If the trial studies one or more U.S. FDA-regulated device products (a device subject to section 510(k), 515, 520(m), or 522 of the Federal Food, Drug, and Cosmetic Act), select Yes. Otherwise, select No. If you select Yes in this field, the Unapproved/Uncleared Device field and Pediatric Post-market Surveillance field become available.

Unapproved/Uncleared Device*

This field is read-only. The default value is No, which indicates the release of trial information on Cancer.gov is not being delayed until after an interventional device has been approved or cleared. You may request a change in the value for this field by submitting a request to the CTRO at ncictro@mail.nih.gov.
Pediatric Post-market Surveillance

If the U.S. FDA has ordered a pediatric post-market surveillance of the device product, select Yes. Otherwise, select No.

Product Exported from the U.S.

If the product is manufactured in the U.S. or one of its territories and exported for study in a clinical trial in another country, select Yes. Otherwise, select No.

FDA Regulated Intervention Indicator*

If the trial is regulated by the FDA, select Yes. (If the trial includes an IND or IDE, you must select Yes.) Otherwise, select No. If you select Yes in this field, the Section 801 Indicator field becomes available.

Section 801 Indicator*

If the FDA-regulated interventional trial is an applicable trial as defined in US Public Law 110-85, Title VIII, Section 801, select Yes. Otherwise, select No.

Data Monitoring Committee Appointed Indicator

Optionally, indicate whether a data monitoring committee has been appointed for this trial by selecting Yes or No.

This information is required for compliance with the Public Law 110-85 of the Food and Drug Administration Amendment Act of 2007. If you are unsure about how to classify a trial, or what information to provide, contact the FDA's regulatory affairs office.

  • No labels